ADOLOR CORP
S-1/A, EX-23.1, 2000-11-08
PHARMACEUTICAL PREPARATIONS
Previous: ADOLOR CORP, S-1/A, EX-10.12, 2000-11-08
Next: FRESH BREATH INDUSTRIES INC, DEFR14A, 2000-11-08



<PAGE>

                                                                    Exhibit 23.1


When the transaction referred to in the second paragraph in Note 12 of the Notes
to Financial Statements has been consummated, we will be in a position to render
the following consent.

                                                                        KPMG LLP

Philadelphia, Pennsylvania
November 8, 20000


                             Accountants' Consent

The Board of Directors
Adolor Corporation:

   We consent to the use of our report included herein and to the reference to
our firm under the heading "Experts" in the Prospectus.




Philadelphia, Pennsylvania


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission